EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study

Go back to EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 34.95 +0.03 (0.09%)
Previous Close $34.92    52 Week High $5.09 
Open $34.95    52 Week Low $1.11 
Day High $34.95    P/E N/A 
Day Low $34.95    EPS $0.00 
Volume 524